CREB1 and Parkinson disease: One of the studies [35] also showed that the rTMS-induced downregulation of microRNA miR-195a-5p (a putative biomarker for PD) with a resultant upregulation of cyclic AMP-response element-binding protein (CREB) may be a mechanism for the observed neuroprotection.